The worldwide vaccine campaign has placed the spotlight on syringes and needles. Healthcare providers are adhering to ISO (International Organization for Standardization) standards to ensure they meet internationally agreed levels of safety and quality. Companies in the hypodermic needles market are capitalizing on business opportunities with unprecedented demand for single-use needles and catheters for blood sampling.
Stakeholders in the healthcare landscape are gaining awareness pertaining to government guidelines about specific properties and requirements for sterile single-use hypodermic syringes. Manufacturers in the hypodermic needles market are maintaining robust supply chains to meet requirements for vaccine campaigns and ongoing COVID-19 cases of patients in hospitals. International standards are proving useful for syringe manufacturers to ensure they comply with World Health Organization (WHO) recommendations.
The hypodermic needles market is predicted to reach US$ 4 Bn by the end of 2031. However, there is a lack of availability of precision-engineered needles for challenging applications in high-throughput processing environments. Terumo Pharmaceutical Solutions - a manufacturer of drug delivery devices, is taking advantage of this opportunity within a challenge to innovate in carefully crafted hypodermic needles that deliver comfort in parenteral therapies.
Companies in the hypodermic needles market are boosting their production capabilities in products that are patient-friendly and help to decrease penetration resistance. Thus, to gain a competitive edge, stakeholders are establishing flexible global sales and supply networks.
Hypodermic needles are facing a stiff competition from needle-free injectors. The NuGen Medical Devices’ needle-free injector is being publicized for the same and are serving as cutting-edge replacements. However, needle-free injectors cannot entirely replace hypodermic needles. Hence, manufacturers in the hypodermic needles market are offering tailored solutions and expert engineering to clients and customers in order to improve patient outcomes.
Manufacturers in the hypodermic needles market are increasing the availability of precision-engineered needles and needle stick prevention technologies to excel in challenging applications and high-throughput processing environments. Companies are providing safe designs and less painful injections to ensure therapeutic success. Robust inspection, quality-assured, and controlled manufacturing of hypodermic needles is being achieved to face the competition placed by needle-free injectors.
Meeting ISO standards has become customary for manufacturers in the hypodermic needles market in order to meet the high standard of quality in materials and for accurately administering medications. The steady demand for syringes has compelled companies to adopt automated systems in inspection and testing processes. Optical and vision systems are being used for random sample checking during production processes.
Surface finish, visual appearance, and cleanliness are forming as important requirements in the hypodermic needles market. Manufacturers are increasing their production capacities in safety hypodermic needles that are carefully crafted to suit a clinician’s needs and assure patient comfort. Patented, reliable, hinged sheath design provides audible, visible, and tangible confirmation of safety for administration of medications.
Analysts’ Viewpoint
With the advent of the global COVID-19 vaccine campaigns, analysts at the Transparency Market Research are anticipating a possible shortage of hypodermic needles and syringes in nations with poor medical resources and infrastructure. The hypodermic needles market is predicted to expand at a favorable CAGR of ~6% during the assessment period. However, advantages such as decline in cross-contamination, increase in availability and subcutaneous delivery of medications with the help of needle-free injectors are posing a threat to the sales of hypodermic needles. Hence, manufacturers should increase the availability of precision-engineered needles and deploy proven track record of reliable supply of syringes to stay relevant, since needle-free injectors cannot entirely replace the performance and need of syringes in challenging high-throughput processing environments.
The global hypodermic needles market was worth US$ 2.1 Bn and is projected to reach a value of US$ 4 Bn by the end of 2031
Hypodermic needles market is anticipated to grow at a CAGR of 6% during the forecast period
North America accounted for a major share of the global hypodermic needles market
Hypodermic needles market is driven by rise in prevalence of chronic diseases and enforcement of legislation mandating the use of safety syringes
Key players in the global hypodermic needles market include Becton, Dickinson and Company, B. Braun Melsungen AG, Medtronic, Smiths Medical, Cardinal Health, Novo Nordisk, Medline Industries, Inc., Terumo Medical Corporation, Cadence Science, and Exelint International, Co.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Hypodermic needles Market Forecast
4.4. Global Hypodermic needles Market Outlook
5. Market Outlook
5.1. Regulatory Scenario
5.2. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.3. Number of Epidural and Cosmetic Surgical Procedures
5.4. Cancer Statistics
5.5. COVID-19 Pandemic Impact on Industry (value chain and short-/ mid-/ long-term impact)
6. Global Hypodermic Needles Market Analysis, by Type
6.1. Introduction
6.2. Global Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type
6.3. Global Hypodermic Needles Market Forecast, by Type
6.3.1. Safety Needles
6.3.2. Non-safety Needles
6.4. Global Hypodermic Needles Market Analysis, by Type
7. Global Hypodermic Needles Market Analysis, by Application
7.1. Introduction
7.2. Global Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application
7.3. Global Hypodermic Needles Market Forecast, by Application
7.3.1. Drug Delivery
7.3.1.1. Chemotherapy
7.3.1.2. Spinal/Epidural Infusion
7.3.1.3. Plastic Surgery
7.3.1.4. Others
7.3.2. Others
7.4. Global Hypodermic Needles Market Analysis, by Application
8. Global Hypodermic Needles Market Analysis, by End-user
8.1. Introduction
8.2. Global Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user
8.3. Global Hypodermic Needles Market Forecast, by End-user
8.3.1. Hospitals
8.3.2. Cancer Treatments Centers
8.3.3. Dermatology Clinics
8.3.4. Others
8.4. Global Hypodermic Needles Market Analysis, by End-user
9. Global Hypodermic Needles Market Analysis, by Region
9.1. Global Hypodermic Needles Market Analysis, by Region
9.2. Global Hypodermic Needles Market Value Share Analysis, by Region
9.3. Global Hypodermic Needles Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
10. North America Hypodermic Needles Market Analysis
10.1. North America Hypodermic Needles Market Overview
10.2. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country
10.3. North America Hypodermic Needles Market Forecast, by Country
10.3.1. U.S.
10.3.2. Canada
10.4. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type
10.5. North America Hypodermic Needles Market Forecast, by Type
10.5.1. Safety Needles
10.5.2. Non-safety Needles
10.6. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application
10.7. North America Hypodermic Needles Market Forecast, by Application
10.7.1. Drug Delivery
10.7.1.1. Chemotherapy
10.7.1.2. Spinal/Epidural Infusion
10.7.1.3. Plastic Surgery
10.7.1.4. Others
10.7.2. Others
10.8. North America Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user
10.9. North America Hypodermic Needles Market Forecast, by End-user
10.9.1. Hospitals
10.9.2. Cancer Treatments Centers
10.9.3. Dermatology Clinics
10.9.4. Others
11. Europe Hypodermic Needles Market Analysis
11.1. Europe Hypodermic Needles Market Overview
11.2. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region
11.3. Europe Hypodermic Needles Market Forecast, by Country/Sub-region
11.3.1. U.K.
11.3.2. France
11.3.3. Italy
11.3.4. Germany
11.3.5. Spain
11.3.6. Rest of Europe
11.4. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type
11.5. Europe Hypodermic Needles Market Forecast, by Type
11.5.1. Safety Needles
11.5.2. Non-safety Needles
11.6. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application
11.7. Europe Hypodermic Needles Market Forecast, by Application
11.7.1. Drug Delivery
11.7.1.1. Chemotherapy
11.7.1.2. Spinal/Epidural Infusion
11.7.1.3. Plastic Surgery
11.7.1.4. Others
11.7.2. Others
11.8. Europe Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user
11.9. Europe Hypodermic Needles Market Forecast, by End-user
11.9.1. Hospitals
11.9.2. Cancer Treatments Centers
11.9.3. Dermatology Clinics
11.9.4. Others
12. Asia Pacific Hypodermic Needles Market Analysis
12.1. Asia Pacific Hypodermic Needles Market Overview
12.2. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Asia Pacific Hypodermic Needles Market Forecast, by Country/Sub-region
12.3.1. Japan
12.3.2. China
12.3.3. India
12.3.4. Australia & New Zealand
12.3.5. Rest of Asia Pacific
12.4. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type
12.5. Asia Pacific Hypodermic Needles Market Forecast, by Type
12.5.1. Safety Needles
12.5.2. Non-safety Needles
12.6. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application
12.7. Asia Pacific Hypodermic Needles Market Forecast, by Application
12.7.1. Drug Delivery
12.7.1.1. Chemotherapy
12.7.1.2. Spinal/Epidural Infusion
12.7.1.3. Plastic Surgery
12.7.1.4. Others
12.7.2. Others
12.8. Asia Pacific Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user
12.9. Asia Pacific Hypodermic Needles Market Forecast, by End-user
12.9.1. Hospitals
12.9.2. Cancer Treatments Centers
12.9.3. Dermatology Clinics
12.9.4. Others
13. Latin America Hypodermic Needles Market Analysis
13.1. Latin America Hypodermic Needles Market Overview
13.2. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Latin America Hypodermic Needles Market Forecast, by Country/Sub-region
13.3.1. Brazil
13.3.2. Mexico
13.3.3. Rest of Latin America
13.4. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type
13.5. Latin America Hypodermic Needles Market Forecast, by Type
13.5.1. Safety Needles
13.5.2. Non-safety Needles
13.6. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application
13.7. Latin America Hypodermic Needles Market Forecast, by Application
13.7.1. Drug Delivery
13.7.1.1. Chemotherapy
13.7.1.2. Spinal/Epidural Infusion
13.7.1.3. Plastic Surgery
13.7.1.4. Others
13.7.2. Others
13.8. Latin America Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user
13.9. Latin America Hypodermic Needles Market Forecast, by End-user
13.9.1. Hospitals
13.9.2. Cancer Treatments Centers
13.9.3. Dermatology Clinics
13.9.4. Others
14. Middle East & Africa Hypodermic Needles Market Analysis
14.1. Middle East & Africa Hypodermic Needles Market Overview
14.2. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Middle East & Africa Hypodermic Needles Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Middle East & Africa
14.4. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by Type
14.5. Middle East & Africa Hypodermic Needles Market Forecast, by Type
14.5.1. Safety Needles
14.5.2. Non-safety Needles
14.6. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by Application
14.7. Middle East & Africa Hypodermic Needles Market Forecast, by Application
14.7.1. Drug Delivery
14.7.1.1. Chemotherapy
14.7.1.2. Spinal/Epidural Infusion
14.7.1.3. Plastic Surgery
14.7.1.4. Others
14.7.2. Others
14.8. Middle East & Africa Hypodermic Needles Market Value Share and Attractiveness Analysis, by End-user
14.9. Middle East & Africa Hypodermic Needles Market Forecast, by End-user
14.9.1. Hospitals
14.9.2. Cancer Treatments Centers
14.9.3. Dermatology Clinics
14.9.4. Others
15. Competition Landscape
15.1. Competition Matrix
15.2. Company Profiles
15.2.1. BD
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Financial Overview
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.2. B. Braun Melsungen AG
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Financial Overview
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.3. Medtronic
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Financial Overview
15.2.3.4. SWOT Analysis
15.2.3.5. Strategic Overview
15.2.4. Cardinal Health
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Financial Overview
15.2.4.4. SWOT Analysis
15.2.4.5. Strategic Overview
15.2.5. Medline Industries, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. SWOT Analysis
15.2.5.4. Strategic Overview
15.2.6. Smiths Medical
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. SWOT Analysis
15.2.6.4. Strategic Overview
15.2.7. Novo Nordisk A/S
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Financial Overview
15.2.7.4. SWOT Analysis
15.2.7.5. Strategic Overview
15.2.8. Terumo Corporation
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. Financial Overview
15.2.8.4. SWOT Analysis
15.2.8.5. Strategic Overview
15.2.9. Cadence Science, Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. SWOT Analysis
15.2.9.4. Strategic Overview
15.2.10. EXELINT International, Co.
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. SWOT Analysis
15.2.10.4. Strategic Overview
List of Tables
Table 01: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 02: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031
Table 04: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 06: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 07: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031
Table 09: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: North America Hypodermic Needles Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 11: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 12: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031
Table 14: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Europe Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 17: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031
Table 19: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Asia Pacific Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 22: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031
Table 24: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Type, 2017–2031
Table 27: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Drug Delivery, 2017–2031
Table 29: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Middle East & Africa Hypodermic Needles Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
List of Figures
Figure 01: Global Hypodermic Needles Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Hypodermic Needles Market Value Share, by Type, 2020
Figure 03: Global Hypodermic Needles Market Value Share, by Application, 2020
Figure 04: Global Hypodermic Needles Market Value Share, by End-user, 2020
Figure 05: Global Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031
Figure 06: Global Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031
Figure 07: Global Hypodermic Needles Market Revenue (US$ Mn), by Safety Needles, 2017–2031
Figure 08: Global Hypodermic Needles Market Revenue (US$ Mn), by Non-safety Needles, 2017–2031
Figure 09: Global Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031
Figure 10: Global Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031
Figure 11: Global Hypodermic Needles Market Revenue (US$ Mn), by Drug Delivery, 2017–2031
Figure 12: Global Hypodermic Needles Market Revenue (US$ Mn), by Others, 2017–2031
Figure 13: Global Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031
Figure 14: Global Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031
Figure 15: Global Hypodermic Needles Market Revenue (US$ Mn), by Hospitals, 2017–2031
Figure 16: Global Hypodermic Needles Market Revenue (US$ Mn), by Cancer Treatment Centers, 2017–2031
Figure 17: Global Hypodermic Needles Market Revenue (US$ Mn), by Dermatology Clinics, 2017–2031
Figure 18: Global Hypodermic Needles Market Revenue (US$ Mn), by Others, 2017–2031
Figure 19: Global Hypodermic Needles Market Value Share, by Region, 2020 and 2031
Figure 20: Global Hypodermic Needles Market Attractiveness Analysis, by Region, 2021–2031
Figure 21: North America Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 22: North America Hypodermic Needles Market Value Share (%), by Country, 2020 and 2031
Figure 23: North America Hypodermic Needles Market Attractiveness Analysis, by Country, 2021–2031
Figure 24: North America Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031
Figure 25: North America Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031
Figure 26: North America Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031
Figure 27: North America Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031
Figure 28: North America Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031
Figure 29: North America Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031
Figure 30: Europe Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 31: Europe Hypodermic Needles Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 32: Europe Hypodermic Needles Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 33: Europe Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031
Figure 34: Europe Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031
Figure 35: Europe Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031
Figure 36: Europe Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031
Figure 37: Europe Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031
Figure 38: Europe Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031
Figure 39: Asia Pacific Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 40: Asia Pacific Hypodermic Needles Market Value Share (%), by Country/Sub-region, 2020 and 2031
Figure 41: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by Country/Sub-region, 2021–2031
Figure 42: Asia Pacific Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031
Figure 43: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031
Figure 44: Asia Pacific Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031
Figure 45: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031
Figure 46: Asia Pacific Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031
Figure 47: Asia Pacific Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031
Figure 48: Latin America Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 49: Latin America Hypodermic Needles Market Value Share (%), by Country Value Share (%), by Country, 2020 and 2031
Figure 50: Latin America Hypodermic Needles Market Attractiveness Analysis, by Country Value Share (%), by Country, 2021–2031
Figure 51: Latin America Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031
Figure 52: Latin America Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031
Figure 53: Latin America Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031
Figure 54: Latin America Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031
Figure 55: Latin America Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031
Figure 56: Latin America Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031
Figure 57: Middle East & Africa Hypodermic Needles Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
Figure 58: Middle East & Africa Hypodermic Needles Market Value Share (%), by Country Value Share (%), by Country, 2020 and 2031
Figure 59: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by Country Value Share (%), by Country, 2021–2031
Figure 60: Middle East & Africa Hypodermic Needles Market Value Share Analysis, by Type, 2020 and 2031
Figure 61: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by Type, 2021–2031
Figure 62: Middle East & Africa Hypodermic Needles Market Value Share Analysis, by Application, 2020 and 2031
Figure 63: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by Application, 2021–2031
Figure 64: Middle East & Africa Hypodermic Needles Market Value Share Analysis, by End-user, 2020 and 2031
Figure 65: Middle East & Africa Hypodermic Needles Market Attractiveness Analysis, by End-user, 2021–2031
Figure 66: BD, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 67: BD, Breakdown of Net Sales (%), by Region/Sub-region, 2020
Figure 68: BD, Breakdown of Net Sales (%), by Business Segment, 2020
Figure 69: B. Braun Melsungen AG, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 70: B. Braun Melsungen AG, Breakdown of Net Sales (%), by Region/Sub-region, 2020
Figure 71: B. Braun Melsungen AG, Breakdown of Net Sales (%), by Business Segment, 2020
Figure 72: Medtronic, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 73: Medtronic, Selling, General, and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 74: Medtronic, Breakdown of Net Sales (%), by Region, 2020
Figure 75: Medtronic, Breakdown of Net Sales (%), by Business Segment, 2020
Figure 76: Cardinal Health, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 77: Cardinal Health, Breakdown of Net Sales (%), by Business Segment, 2020
Figure 78: Cardinal Health, Breakdown of Net Sales (%), by Region, 2020
Figure 79: Novo Nordisk A/S, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020
Figure 80: Novo Nordisk A/S, Breakdown of Net Sales (%), by Region/Country, 2020
Figure 81: Novo Nordisk A/S, Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2020, by Business Segments
Figure 82: Novo Nordisk A/S, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 83: Terumo Corporation, Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2020
Figure 84: Terumo Corporation, Breakdown of Net Sales (%), by Region/Sub-region, 2020
Figure 85: Terumo Corporation, Breakdown of Net Sales (%), by Business Segment, 2020
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Hypodermic Needles Market
